STAT | Reporting from the frontiers of health and medicine

Skip to Main Content

Explore what it takes to make the health care system work.

Explore what it takes to make the health care system work.

October 31, 2024

STAT Plus: To mitigate drug shortages, a new study suggests looking at Canada
October 31, 2024

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story
October 31, 2024

Limiting sugar in infancy is tied to less diabetes and hypertension in adulthood
October 31, 2024

STAT Plus: Two generic drugmakers pay $49 million to settle price-fixing charges
October 31, 2024

STAT Plus: Teva fined $503 million for disparaging a rival and using patents to thwart competition
October 31, 2024

STAT Plus: Trump, RFK Jr., and biotech stocks: Buckle up!

How UnitedHealth Group wields its physician empire to boost its profits

Read the series

How science journals are confronting the ‘existential’ question of politics this election

Editors of scientific journals ponder the role of science in politics today, and whether wading into politics might erode trust in scientific institutions.

First Opinion November 1, 2024

Doctors: To get your patients to share, stop judging them when they do

Who to Know October 31, 2024

STAT Plus: These 10 scientists are leading a new generation of gene editors developing CRISPR medicines

First Opinion November 1, 2024

STAT Plus: Precision medicine can’t fulfill its promise without better diagnostics

First Opinion October 30, 2024

I’m a geriatric physician. Here’s what I think is going on with Trump’s executive function

Sponsored

Advertisement

Sign up for Newsletters

STAT+

Your go-to source for the world of life sciences, medicine, and biopharma. Subscribe now.

Cancel anytime.

STAT Plus: It’s time for a new medical specialty in asynchronous care

STAT Plus: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

STAT Plus: These 10 scientists are leading a new generation of gene editors developing CRISPR medicines

STAT Plus: Apple claims new AirPod hearing aid feature is ‘clinical grade.’ Is it?

STAT Plus: Early data from Roche’s Alzheimer’s therapy show it’s hitting targets

All STAT+ Stories

All Events

More From STAT

More From STAT

More From STAT

STAT offers a variety of in-person and virtual events throughout the year.

All Events

STAT @ ASH: From Sickle Cell to Cancer

San Diego, CA December 8, 2024

Join STAT at the 66th annual American Society of Hematology Annual Meeting.

04

Nov

Advancing Severe Migraine Care

Virtual

21

Nov

The Business of Biotech – What You Need to Know Going into 2025

Boston, MA

All Events

All Trackers

More From STAT

More From STAT

More From STAT

We create tools to help you understand and track complex areas of development.

All Trackers

Obesity Drug Tracker

Here are the dozens of weight loss drugs in development to catch a booming market.

CRISPR Tracker

Follow the latest developments in genome editing.

Generative AI Tracker

A guide to the health systems and companies driving adoption.

Breakthrough Device Tracker

An authoritative database of FDA’s fast-tracked medical devices.

All Reports

More From STAT

More From STAT

More From STAT

STAT Reports blend data insights with qualitative observations on pivotal life sciences topics.

All Reports

STAT’s guide to interpreting clinical trial results

$49

Our bestselling report is now updated to help you read clinical trial results with an appropriately skeptical (or critical) eye.

A new generation of drugs is transforming the way scientists think about the illness.

Interpreting clinical trial results is not for the faint of heart…

All Podcasts

More From STAT

More From STAT

More From STAT

From policy to practice: STAT's podcasts decode health care complexities.

All Podcasts

The Readout LOUD

Our weekly biotech podcast digs deep into industry goings-on.

First Opinion Podcast

Our opinion podcast discusses the people, issues, and ideas that are shaping health care.

Color Code

Our podcast raising the alarm on racial inequities in American health care.

More From STAT

Events Trackers Reports Podcasts

More Stories

Pharmalot October 31, 2024

STAT Plus: To mitigate drug shortages, a new study suggests looking at Canada

The Readout LOUD October 31, 2024

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story

Health October 31, 2024

Limiting sugar in infancy is tied to less diabetes and hypertension in adulthood

Pharmalot October 31, 2024

STAT Plus: Two generic drugmakers pay $49 million to settle price-fixing charges

Pharmalot October 31, 2024

STAT Plus: Teva fined $503 million for disparaging a rival and using patents to thwart competition

Adam's Take October 31, 2024

STAT Plus: Trump, RFK Jr., and biotech stocks: Buckle up!

Adam's Take October 31, 2024

STAT Plus: Capricor and the FDA: A daring, risky filing strategy

Biotech October 31, 2024

STAT Plus: Small mid-stage trial suggests targeted magnetic pulses to brain could slow Alzheimer’s

First Opinion October 31, 2024

Medicare’s hidden information hurts people, policy

Health tech October 31, 2024

STAT Plus: Apple claims new AirPod hearing aid feature is ‘clinical grade.’ Is it?

First Opinion October 31, 2024

What Trump and RFK Jr.’s ‘Make America Healthy Again’ gets right — and very wrong

Health October 31, 2024

Should race be used in clinical algorithms? How one doctor’s research is helping shape policy

Pharmalot October 31, 2024

STAT Plus: Pharmalittle: We’re reading about the FDA listing Novo drugs as ‘available,’ pharma layoffs, and more

Health October 30, 2024

STAT Plus: Novo Nordisk’s Ozempic and Wegovy, long in shortage, are now listed as available by FDA

Pharmalot October 30, 2024

STAT Plus: Pharmalittle: We’re reading about disappointing Lilly sales, a Roche Alzheimer’s therapy, and more

Pharma October 30, 2024

STAT Plus: Eli Lilly hits rare stumble, as sales and earnings disappoint

Pharma October 30, 2024

STAT Plus: Sales of GSK’s RSV vaccine down dramatically from last year

Biotech October 30, 2024

STAT Plus: With $115 million, biotech startup Axonis Therapeutics pivots to burgeoning pain field

First Opinion November 1, 2024

Doctors: To get your patients to share, stop judging them when they do

First Opinion November 1, 2024

STAT Plus: Precision medicine can’t fulfill its promise without better diagnostics

Adam's Take October 31, 2024

STAT Plus: Trump, RFK Jr., and biotech stocks: Buckle up!

Adam's Take October 31, 2024

STAT Plus: Capricor and the FDA: A daring, risky filing strategy

First Opinion October 31, 2024

What Trump and RFK Jr.’s ‘Make America Healthy Again’ gets right — and very wrong

First Opinion October 31, 2024

Medicare’s hidden information hurts people, policy

Newsletters

Mon - Fri

Your daily dose of news in health and science

Our Picks

Our Picks

STAT’s selection of must-read stories and investigations

Drinking is cheaper than it’s been in decades. Lobbyists are fighting to keep it that way

By Isabella Cueto

STAT Plus: How a Kamala Harris presidency would change health care, from drug pricing to abortion

By Rachel Cohrs Zhang

STAT Plus: Perplexing results from Duchenne muscular dystrophy trial raise questions about gene therapies

By Jason Mast and Adam Feuerstein

STAT Plus: What’s on the docket for Congress post-election: Chinese biotech, Medicare payments, ACA subsidies

By John Wilkerson

STAT Plus: Frustrated with Change Healthcare breach, senators propose removing limits on HIPAA fines

By Brittany Trang

‘Do no harm’ is hurting 400 million long Covid patients worldwide

By Julia Moore Vogel and Charlie McCone

STAT Plus: For the behemoth UnitedHealth, a new threat to Medicare profits

By Tara Bannow and Casey Ross

Dietary guidelines panel stresses fruits and vegetables but stops shy of major changes

By Elizabeth Cooney

STAT Plus: Eli Lilly says modified dosing of its Alzheimer’s drug may be safer

Biotech October 29, 2024

STAT Plus: Eli Lilly says modified dosing of its Alzheimer’s drug may be safer

Biotech October 29, 2024

STAT Plus: VCs move to launch U.S.-based companies to advance drugs developed in China

Biotech October 28, 2024

STAT Plus: Novartis, Seagen veteran David Epstein is back, leading a new cancer startup

AstraZeneca’s China president is under investigation by authorities

Pharmalot October 30, 2024

AstraZeneca’s China president is under investigation by authorities

Pharmalot October 29, 2024

STAT Plus: Pharmalittle: We’re reading about Charles River monkey shipments, VC partners for Chinese companies, and more

Pharma October 29, 2024

STAT Plus: Pfizer beats earnings expectations in first report after criticism by activist investor

National Academies calls to change how biomedical research uses race and ethnicity

Health October 30, 2024

National Academies calls to change how biomedical research uses race and ethnicity

Health October 29, 2024

Q&A: Why drafting new rules on ultra-processed foods is so hard

Health October 28, 2024

Tracking the U.S. bird flu outbreak has been hard. It’s about to get harder

6 races to watch that could shape health care policy

Politics October 29, 2024

6 races to watch that could shape health care policy

Politics October 28, 2024

STAT Plus: How a Donald Trump presidency would change health care, from Medicaid to the CDC

Politics October 24, 2024

STAT Plus: The key ballot measures and races to watch that could reshape health care

Video

Ability to wed: When getting married could mean losing lifesaving medical benefits

How a tragic diagnosis sent a journalist on a scientific odyssey

A history of mpox so far

STAT Plus: The little-known bill that made drugs more affordable

Health

Health

STAT Plus: Digital ‘avatars’ emerging as effective treatment for psychosis

Health tech October 28, 2024

STAT Plus: Digital ‘avatars’ emerging as effective treatment for psychosis

Health tech October 24, 2024

STAT Plus: General Catalyst raises $8 billion, with $750 million for health care bets

Health tech October 23, 2024

STAT Plus: Retina implant partially improved eyesight in people with severe vision loss

Using AI, images are fueling a new boom in cell biology

In the Lab October 21, 2024

Using AI, images are fueling a new boom in cell biology

In the Lab October 18, 2024

STAT Plus: Chickenpox, shingles, Alzheimer’s? Evidence mounts for a viral cause of dementia

In the Lab October 14, 2024

STAT Plus: Broad Institute announces layoffs, largely in IT, software engineering

STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks

Hospitals September 26, 2024

STAT Plus: Two reports, two dramatically different views of nonprofit hospitals’ tax breaks

Hospitals September 6, 2024

STAT Plus: Ascension, other hospitals played active roles to take medical billing company R1 RCM private

Hospitals September 3, 2024

STAT Plus: Dana-Farber CEO Laurie Glimcher to step down, saying ‘we must look to the next generation’

STAT Plus: Ballooning Medicaid costs challenge health insurer Elevance

Insurance October 17, 2024

STAT Plus: Ballooning Medicaid costs challenge health insurer Elevance

Insurance October 17, 2024

STAT Plus: Medicare Advantage insurers ramped up use of technology to deny claims, Senate investigation shows

Insurance October 4, 2024

STAT Plus: Medicare Advantage market expected to grow in 2025, despite big changes from insurers

Podcasts

Lilly’s earnings surprise, investors mull the election, & a spooky ghost story

Abortion is just another part of medicine

Pfizer’s activist troubles, gene therapy questions, RFK Jr.’s MAHA ambitions

Biotech’s next gold rush, GLP-1 shortages, and STAT Summit highlights